Indication
Myocardial reinfarction prevention
Myocardial reinfarction prevention refers to secondary prevention strategies directed at patients who have previously experienced an acute myocardial infarction to stop or reduce the risk of a recurrent ischemic cardiac event. Read more about Myocardial reinfarction prevention
361 drugs 181 manufacturers
Drugs that treat it
Common Myocardial reinfarction prevention therapies.
ENTERIC COATED ASPIRIN (aspirin)
ENTERIC COATED ASPIRIN (aspirin)
ENTERIC COATED ASPIRIN (aspirin)
JANTOVEN (warfarin sodium)
METOPROLOL TARTRATE
NIACIN ER (niacin)
METOPROLOL TARTRATE
NIACIN ER (niacin)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMyocardial reinfarction prevention refers to secondary prevention strategies directed at patients who have previously experienced an acute myocardial infarction to stop or reduce the risk of a recurrent ischemic cardiac event.
It addresses the cardiovascular system, specifically targeting the coronary vasculature and myocardium in individuals with established coronary artery disease.
Pathophysiologically, these patients carry a heightened risk of subsequent plaque rupture, erosion, coronary thrombosis, and further myocardial necrosis, which can lead to progressive ventricular dysfunction, heart failure, or cardiovascular death.
Clinically, prevention is defined by long-term management aimed at stabilizing atherosclerotic plaques, suppressing platelet aggregation, and mitigating myocardial oxygen demand to prevent re-occlusion and recurrent infarction.
- nih.gov
Myocardial reinfarction prevention refers to secondary prevention strategies directed at patients who have previously experienced an acute myocardial infarction to stop or reduce the risk of a recurrent ischemic cardiac event Clinically, prevention is defined by long-term management aimed at stabilizing atherosclerotic plaques, suppressing platelet aggregation, and mitigating myocardial oxygen demand to prevent re-occlusion and recurrent infarction
- nih.gov
Myocardial reinfarction prevention refers to secondary prevention strategies directed at patients who have previously experienced an acute myocardial infarction to stop or reduce the risk of a recurrent ischemic cardiac event It addresses the cardiovascular system, specifically targeting the coronary vasculature and myocardium in individuals with established coronary artery disease
- nih.gov
It addresses the cardiovascular system, specifically targeting the coronary vasculature and myocardium in individuals with established coronary artery disease Pathophysiologically, these patients carry a heightened risk of subsequent plaque rupture, erosion, coronary thrombosis, and further myocardial necrosis, which can lead to progressive ventricular dysfunction, heart failure, or cardiovascular death Clinically, prevention is defined by long-term management aimed at stabilizing atheroscleroti...
- nih.gov
Pathophysiologically, these patients carry a heightened risk of subsequent plaque rupture, erosion, coronary thrombosis, and further myocardial necrosis, which can lead to progressive ventricular dysfunction, heart failure, or cardiovascular death
Personalize your experience
Follow Myocardial reinfarction prevention and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.